10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
12.29
-0.51 (-3.98%)
At close: Aug 8, 2025, 4:00 PM
12.48
+0.19 (1.55%)
After-hours: Aug 8, 2025, 7:57 PM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $1.53 billion as of August 8, 2025. Its market cap has decreased by -32.63% in one year.
Market Cap
1.53B
Enterprise Value
1.17B
1-Year Change
-32.63%
Ranking
Category
Stock Price
$12.29
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $1.53B, a decrease of -69.09%. That is a compound annual growth rate of -18.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 1.51B | -12.94% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 566.10B |
| Johnson & Johnson | 417.85B |
| AbbVie | 351.53B |
| Abbott Laboratories | 234.35B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 226.27B |
| Novartis AG | 225.61B |
| Novo Nordisk | 213.92B |